Follow the people · Insider
WALTERS GROUP
WALTERS GROUP files insider transactions with the SEC as a 10% owner of Zentalis Pharmaceuticals (ZNTL). We hold 2 disclosed purchases and sales filed since 8 January 2026, 1 of them in the last 90 days.
- Files forZNTL
- Disclosed buys and sells2 in all, 1 in the last 90 days
- Last disclosure19 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 31 December 2025 — 14 August 202610% owner · Zentalis Pharmaceuticals (ZNTL)2 Form 4 lines · source: SEC Form 4
Everything they disclosed
2 entries, newest first — one per disclosure report, one per Form 4 line- ▲ bought on the open market 4,335,000 shares of Zentalis PharmaceuticalsSEC Form 419 August 2026Common Stock · traded 14 August 2026 · filed 19 August 2026
- ▲ bought on the open market 6,459,973 shares of Zentalis PharmaceuticalsSEC Form 48 January 2026Common Stock · traded 31 December 2025 · filed 8 January 2026
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.